Monitoring symptoms at home: what methods would cancer patients be comfortable using?

PubWeight™: 0.80‹?›

🔗 View Article (PMID 20446045)

Published in Qual Life Res on May 06, 2010

Authors

Annet Kleiboer1, Katie Gowing, Christian Holm Hansen, Carina Hibberd, Laura Hodges, Jane Walker, Parvez Thekkumpurath, Mark O'Connor, Gordon Murray, Michael Sharpe

Author Affiliations

1: Psychological Medicine Research, School of Molecular and Clinical Medicine, University of Edinburgh, Kennedy Tower, Royal Edinburgh Hospital, Edinburgh, EH10 5HF, UK. annet.kleiboer@ed.ac.uk

Articles by these authors

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet (2012) 10.30

Psychological medicine and the future of psychiatry. Br J Psychiatry (2014) 4.48

Systematic review of misdiagnosis of conversion symptoms and "hysteria". BMJ (2005) 4.25

Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2002) 3.93

Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet (2008) 3.79

Early supported discharge services for stroke patients: a meta-analysis of individual patients' data. Lancet (2005) 3.56

Somatic symptom disorder: an important change in DSM. J Psychosom Res (2013) 3.40

Chronic fatigue syndrome: a step towards agreement. Lancet (2002) 2.99

Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry (2005) 2.81

Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system. J Clin Oncol (2005) 2.69

Are electronic diaries useful for symptoms research? A systematic review. J Psychosom Res (2007) 2.66

What should we say to patients with symptoms unexplained by disease? The "number needed to offend". BMJ (2002) 2.20

A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst (2008) 2.17

Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial. Stroke (2014) 2.11

Charting a course for your future: a directory of clinical nurse specialist programs in the United States. Clin Nurse Spec (2003) 2.03

Organising care for chronic illness. BMJ (2002) 1.95

Transcriptional inhibition of genes with severe histone h3 hypoacetylation in the coding region. Mol Cell (2002) 1.91

Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys (2003) 1.89

Uncritical positive regard? Issues in the efficacy and safety of psychotherapy. J Psychopharmacol (2008) 1.80

Eliot Slater's myth of the non-existence of hysteria. J R Soc Med (2005) 1.78

Rasch fit statistics and sample size considerations for polytomous data. BMC Med Res Methodol (2008) 1.77

Is there a better term than "medically unexplained symptoms"? J Psychosom Res (2010) 1.77

Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys (2004) 1.70

Revising the classification of somatoform disorders: key questions and preliminary recommendations. Psychosomatics (2007) 1.63

Somatoform disorders in DSM-V. Psychosomatics (2003) 1.62

Statistical analysis plan for the third International Stroke Trial (IST-3); part of a 'thread' of reports of the trial. Int J Stroke (2012) 1.59

Cognitive-behavioural group treatment for a range of functional somatic syndromes: randomised trial. Br J Psychiatry (2012) 1.57

Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol (2006) 1.55

Can clinical features distinguish between immobile patients with stroke at high and low risk of deep vein thrombosis? Statistical modelling based on the CLOTS trials cohorts. J Neurol Neurosurg Psychiatry (2011) 1.54

Somatoform disorders-new approaches to classification, conceptualization, and treatment. J Psychosom Res (2004) 1.53

Better off dead: suicidal thoughts in cancer patients. J Clin Oncol (2008) 1.46

Proteasome-mediated processing of Def1, a critical step in the cellular response to transcription stress. Cell (2013) 1.46

Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J Psychosom Res (2007) 1.24

Fatigue after stroke: the development and evaluation of a case definition. J Psychosom Res (2007) 1.20

Healthcare costs incurred by patients repeatedly referred to secondary medical care with medically unexplained symptoms: a cost of illness study. J Psychosom Res (2012) 1.17

Evaluation of fatigue scales in stroke patients. Stroke (2007) 1.17

The microcirculation as a functional system. Crit Care (2005) 1.16

Enhanced hippocampal long-term potentiation and spatial learning in aged 11beta-hydroxysteroid dehydrogenase type 1 knock-out mice. J Neurosci (2007) 1.14

Spreading of Sir3 protein in cells with severe histone H3 hypoacetylation. Proc Natl Acad Sci U S A (2003) 1.13

Recruiting South Asians to a lifestyle intervention trial: experiences and lessons from PODOSA (Prevention of Diabetes & Obesity in South Asians). Trials (2011) 1.11

Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst Rev (2010) 1.10

Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experience. Can J Anaesth (2011) 1.10

Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatin. Cancer Res (2009) 1.10

A history of liaison psychiatry in the UK. BJPsych Bull (2016) 1.08

Observer variation in the assessment of outcome in traumatic brain injury: experience from a multicenter, international randomized clinical trial. Neurosurgery (2007) 1.08

La belle indifférence in conversion symptoms and hysteria: systematic review. Br J Psychiatry (2006) 1.08

FMRI in patients with motor conversion symptoms and controls with simulated weakness. Psychosom Med (2007) 1.05

Interventions for post-stroke fatigue. Cochrane Database Syst Rev (2009) 1.04

Screening for major depression in cancer outpatients: the diagnostic accuracy of the 9-item patient health questionnaire. Cancer (2010) 1.03

Integrating psychosocial care into cancer services. J Clin Oncol (2012) 1.02

Sitting time and waist circumference are associated with glycemia in U.K. South Asians: data from 1,228 adults screened for the PODOSA trial. Diabetes Care (2011) 1.02

The science of clinical practice: disease diagnosis or patient prognosis? Evidence about "what is likely to happen" should shape clinical practice. BMC Med (2015) 1.01

Issues for DSM-5: Conversion disorder. Am J Psychiatry (2010) 1.01

Thoughts of death and suicide reported by cancer patients who endorsed the "suicidal thoughts" item of the PHQ-9 during routine screening for depression. Psychosomatics (2011) 1.01

The familial risk of subarachnoid haemorrhage. Brain (2005) 1.01

INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial. Inflamm Bowel Dis (2011) 1.00

Screening for suicidality in cancer patients using Item 9 of the nine-item patient health questionnaire; does the item score predict who requires further assessment? Gen Hosp Psychiatry (2010) 0.99

Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization. J Am Coll Surg (2003) 0.99

Conversion disorder: current problems and potential solutions for DSM-5. J Psychosom Res (2011) 0.99

Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis. J Pain Symptom Manage (2011) 0.98

Can neuroimaging help us to understand and classify somatoform disorders? A systematic and critical review. Psychosom Med (2011) 0.98

Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. PLoS One (2012) 0.98

Diagnosing major depression in medical outpatients: acceptability of telephone interviews. J Psychosom Res (2003) 0.97

Unexplained symptoms after terrorism and war: an expert consensus statement. J Occup Environ Med (2003) 0.97

Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy. J Clin Endocrinol Metab (2008) 0.97

Dualism persists in the science of mind. Ann N Y Acad Sci (2009) 0.97

Brain blood flow in the neurological determination of death: Canadian expert report. Can J Neurol Sci (2008) 0.96

Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003). Int J Stroke (2010) 0.96

Neurology, psychiatry, and neuroscience. Am J Psychiatry (2003) 0.95

Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats. J Neurosci (2002) 0.94

Techniques to modulate radiotherapy toxicity and outcome in soft tissue sarcoma. Curr Treat Options Oncol (2003) 0.93

The detection and management of emotional distress in cancer patients: the views of health-care professionals. Psychooncology (2011) 0.93

Motor conversion symptoms and pseudoseizures: a comparison of clinical characteristics. Psychosomatics (2004) 0.93

A longitudinal study of bone density in midlife women. Health Care Women Int (2002) 0.93

Five-year experience with donation after cardiac death kidney transplantation in a Canadian transplant program: Factors affecting outcomes. Can Urol Assoc J (2012) 0.91

Patients repeatedly referred to secondary care with symptoms unexplained by organic disease: prevalence, characteristics and referral pattern. Fam Pract (2010) 0.91

Patient and general practitioner preferences for the treatment of depression in patients with cancer: how, who, and where? J Psychosom Res (2009) 0.90

Fear of recurrence and beliefs about preventing recurrence in persons who have suffered a stroke. J Psychosom Res (2006) 0.90

The symptom of functional weakness: a controlled study of 107 patients. Brain (2010) 0.90

Sleep problems in cancer patients: prevalence and association with distress and pain. Psychooncology (2011) 0.90